MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Leiomyosarcoma · Liposarcoma · Synovial Sarcoma · Angiosarcoma · Undifferentiated Pleomorphic Sarcoma · Epithelioid Sarcoma · Malignant Peripheral Nerve Sheath Tumors · Fibrosarcoma · Pleomorphic Rhabdomyosarcoma · Endometrial Stromal Sarcoma · Desmoplastic Small Round Cell Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen University Cancer Center, Guangzhou, China
Contact: Study coordinator (Xing Zhang, MD,PHD) · zhangxing@sysucc.org.cn · 02087343383
Contact: Principal Investigator (Xing Zhang)

Study leads

Xing Zhang
Principal Investigator
Sun Yat-Sen University Cancer Center
Zhang Xing
Principal Investigator
Sun Yat-Sen University Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Sarcoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Solid Tumor · Sarcoma · Leiomyosarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Lake Success, United States · Houston, United States

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Leiomyosarcoma · Sarcoma

Abroad (travel likely)RecruitingPHASE2

Columbus, United States

IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

Soft Tissue Sarcomas · Angiosarcoma · Fibrosarcoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China